Artelo Biosciences (ARTL) EBIT (QoQ) (2014 - 2025)
Powered by 
Analysis
Artelo Biosciences (ARTL) EBIT (QoQ) (2014 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Artelo Biosciences | 120,340.96 | -479,659.04 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.81% |
| Sep 30, 2025 | 1.94% |
| Jun 30, 2025 | -32.41% |
| Mar 31, 2025 | 37.59% |
| Dec 31, 2024 | -219.00% |
| Sep 30, 2024 | 52.43% |
| Jun 30, 2024 | 2.97% |
| Mar 31, 2024 | 20.09% |
| Dec 31, 2023 | -23.95% |
| Sep 30, 2023 | -46.52% |
| Jun 30, 2023 | 22.16% |
| Mar 31, 2023 | 34.06% |
| Dec 31, 2022 | -45.20% |
| Sep 30, 2022 | 3.12% |
| Jun 30, 2022 | -26.98% |
| May 31, 2021 | -20.56% |
| Feb 28, 2021 | -30.05% |
| Nov 30, 2020 | -39.74% |
| Aug 31, 2020 | -8.01% |
| May 31, 2020 | 30.58% |